This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Heilpern, A. J.
Right arrow Articles by Hu, L. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heilpern, A. J.
Right arrow Articles by Hu, L. T.

 Previous Article  |  Next Article 

Infection and Immunity, July 2009, p. 2643-2649, Vol. 77, No. 7
0019-9567/09/$08.00+0     doi:10.1128/IAI.00214-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Matrix Metalloproteinase 9 Plays a Key Role in Lyme Arthritis but Not in Dissemination of Borrelia burgdorferi{triangledown}

Andrew J. Heilpern,1 Warren Wertheim,1 Jia He,1 George Perides,2 Roderick T. Bronson,3 and Linden T. Hu1*

Division of Geographic Medicine and Infectious Disease, Department of Medicine, Tufts Medical Center, Boston, Massachusetts 02111,1 Department of Surgery, Tufts Medical Center, Boston, Massachusetts 02111,2 Department of Pathology, Harvard Medical School, Boston, Massachusetts 021153

Received 24 February 2009/ Returned for modification 28 March 2009/ Accepted 3 April 2009

Borrelia burgdorferi, the causative agent of Lyme arthritis, does not produce any exported proteases capable of degrading extracellular matrix despite the fact that it is able to disseminate from a skin insertion site to infect multiple organs. Prior studies have shown that B. burgdorferi induces the host protease, matrix metalloproteinase 9 (MMP-9), and suggested that the induction of MMP-9 may allow the organism to disseminate and produce local tissue destruction. We examined the role of MMP-9 in dissemination of B. burgdorferi and pathogenesis of Lyme arthritis. In a MMP-9–/– mouse model, MMP-9 was not required for the dissemination of the spirochete to distant sites. However, MMP-9–/– exhibited significantly decreased arthritis compared to wild-type mice. The decrease in arthritis was not due to an inability to control infection since the spirochete numbers in the joints were identical. Levels of inflammatory chemokines and cytokines were also similar in MMP-9–/– and wild-type mice. We examined whether decreased inflammation in MMP-9–/– mice may be the result of decreased production of neoattractants by MMP-9-dependent cleavage of collagen. MMP-9 cleavage of type I collagen results in increased monocyte chemoattraction. MMP-9 plays an important role in regulating inflammation in Lyme arthritis, potentially through the cleavage of type I collagen.


* Corresponding author. Mailing address: Tufts Medical Center, Box 041, 800 Washington Street, Boston, MA 02111. Phone: (617) 636-8498. Fax: (617) 636-3216. E-mail: Lhu{at}tuftsmedicalcenter.org

{triangledown} Published ahead of print on 13 April 2009.

Editor: A. J. Bäumler


Infection and Immunity, July 2009, p. 2643-2649, Vol. 77, No. 7
0019-9567/09/$08.00+0     doi:10.1128/IAI.00214-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.